Paper42373232
Germline Variation in Notch Pathway and Survival After Androgen Deprivation Therapy in Prostate Cancer: Implicating YAP1 rs1894116 and Focal Adhesion Signaling.
Chung WH and 7 others. Cancer Genomics Proteomics, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Germline Variation in Notch Pathway and Survival After Androgen Deprivation Therapy in Prostate Cancer: Implicating YAP1 rs1894116 and Focal Adhesion Signaling. Papers, record 42373232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42373232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Germline Variation in Notch Pathway and Survival After Androgen Deprivation Therapy in Prostate Cancer: Implicating YAP1 rs1894116 and Focal Adhesion Signaling.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Polymorphism, Single Nucleotide | Major topic |
| Transcription Factors | Major topic |
| Receptors, Notch | Major topic |
| Adaptor Proteins, Signal Transducing | Major topic |
| Androgen Antagonists | Major topic |
| Focal Adhesions | Major topic |
| Germ-Line Mutation | Major topic |
| Humans | |
| Male | |
| YAP-Signaling Proteins | |
| Signal Transduction | |
| Prognosis | |
| Aged | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29665979 | Crosstalk between YAP/TAZ and Notch Signaling. | Trends Cell Biol | 2018 | https://conductscience.org/library/papers/29665979 | PubMed |
| 2 | 39137963 | Genetics of prostate cancer: a review of latest evidence. | J Med Genet | 2024 | https://conductscience.org/library/papers/39137963 | PubMed |
| 3 | 31515154 | Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial. | Lancet Oncol | 2019 | https://conductscience.org/library/papers/31515154 | PubMed |
| 4 | 29906450 | Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer. | Cell | 2018 | https://conductscience.org/library/papers/29906450 | PubMed |
| 5 | 21445969 | Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy. | Int J Cancer | 2012 | https://conductscience.org/library/papers/21445969 | PubMed |
| 6 | 36588499 | YAP antagonizes TEAD-mediated AR signaling and prostate cancer growth. | EMBO J | 2023 | https://conductscience.org/library/papers/36588499 | PubMed |
| 7 | 33428889 | YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance. | Dev Biol | 2021 | https://conductscience.org/library/papers/33428889 | PubMed |
| 8 | 19379690 | The canonical Notch signaling pathway: unfolding the activation mechanism. | Cell | 2009 | https://conductscience.org/library/papers/19379690 | PubMed |
| 9 | 23359804 | Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer. | PLoS One | 2013 | https://conductscience.org/library/papers/23359804 | PubMed |
| 10 | 41179317 | Clinical Outcomes and Prognostic Significance of PSA90 in Patients With Prostate Cancer and Initial PSA >1,000 ng/ml at Diagnosis. | Cancer Diagn Progn | 2025 | https://conductscience.org/library/papers/41179317 | PubMed |
| 11 | 32466188 | Genetic Analysis Reveals a Significant Contribution of CES1 to Prostate Cancer Progression in Taiwanese Men. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32466188 | PubMed |
| 12 | 29892016 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. | Nat Genet | 2018 | https://conductscience.org/library/papers/29892016 | PubMed |
| 13 | 29136207 | LinkedOmics: analyzing multi-omics data within and across 32 cancer types. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29136207 | PubMed |
| 14 | 27433846 | Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. | N Engl J Med | 2016 | https://conductscience.org/library/papers/27433846 | PubMed |
| 15 | 34490262 | Interplay Between Notch and YAP/TAZ Pathways in the Regulation of Cell Fate During Embryo Development. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34490262 | PubMed |
| 16 | 40571313 | Prognostic Significance of EZH2-Related Gene Variants in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy. | Cancer Genomics Proteomics | 2025 | https://conductscience.org/library/papers/40571313 | PubMed |
| 17 | 26746459 | Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. | JAMA | 2016 | https://conductscience.org/library/papers/26746459 | PubMed |
| 18 | 23128226 | An integrated map of genetic variation from 1,092 human genomes. | Nature | 2012 | https://conductscience.org/library/papers/23128226 | PubMed |
| 19 | 33582842 | Context-dependent roles of YAP/TAZ in stem cell fates and cancer. | Cell Mol Life Sci | 2021 | https://conductscience.org/library/papers/33582842 | PubMed |
| 20 | 15466172 | JAGGED1 expression is associated with prostate cancer metastasis and recurrence. | Cancer Res | 2004 | https://conductscience.org/library/papers/15466172 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| VCL | 7414 | PubTator's text mining | https://conductscience.org/library/genes/7414 | NCBI Gene |
| YAP1 | 10413 | PubTator's text mining | https://conductscience.org/library/genes/10413 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42373232
GET https://conductscience.org/api/papers/v1/42373232/references?page=2